Assignee
BISCAYNE NEUROTHERAPEUTICS INC
US·2 granted patents·3 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
5 records- 0173US2026076910A1Use of higher doses of modified release huperzine formulationsBISCAYNE NEUROTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0266US12502356B2Use of higher doses of modified release huperzine formulationsBISCAYNE NEUROTHERAPEUTICS INC·Filed 2022·Granted Dec 23, 2025·0 cites·14 claims
- 0365US2025295601A1Modified release pharmaceutical compositions of huperzine and methods of using the sameBISCAYNE NEUROTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0464US12311060B2Modified release pharmaceutical compositions of huperzine and methods of using the sameBISCAYNE NEUROTHERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·34 claims
- 0555US2018333365A1Modified release pharmaceutical compositions of huperzine and methods of using the sameBISCAYNE NEUROTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BISCAYNE NEUROTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →